Efficacy of SGLT2 inhibitors in patients with heart failure: An overview of systematic reviews-Reference-Cited by-同舟云学术

Efficacy of SGLT2 inhibitors in patients with heart failure: An overview of systematic reviews

Published:2023-04 Issue: Volume:377 Page:79-85
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Sephien Andrew,Ghobrial Mike,Reljic Tea,Prida Xavier,Nerella Nishant,Kumar Ambuj

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference36 articles.

1. Heart disease and stroke statistics-2019 update: a report from the American Heart Association;Benjamin;Circulation,2019

2. Effects and safety of SGLT2 inhibitors compared to placebo in patients with heart failure: a systematic review and meta-analysis;Chambergo-Michilot;Int. J. Cardiol. Heart. Vasc.,2021

3. A novel approach to medical management of heart failure with reduced ejection fraction;Miller;Can. J. Cardiol.,2021

4. Heart failure with preserved ejection fraction in perspective;Pfeffer;Circ. Res.,2019

5. Cardiovascular outcomes with ertugliflozin in type 2 diabetes;Cannon;N. Engl. J. Med.,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early initiation of sodium-glucose cotransporter 2 inhibitors in patients undergoing cardiac surgery: Are we ready for prime time?;International Journal of Cardiology;2024-11

2. Sodium–Glucose Transporter 2 Inhibitors in Heart Failure: An Overview of Systematic Reviews;Journal of Cardiovascular Development and Disease;2024-06-28

3. Practice patterns and clinical outcomes of severe coronary artery disease in dialysis patients;International Journal of Cardiology;2023-07